Literature DB >> 15261708

Depressive syndrome in major psychoses: a study on 1351 subjects.

Alessandro Serretti1, Laura Mandelli, Enrico Lattuada, Enrico Smeraldi.   

Abstract

The aim of this study was to investigate depressive symptomatology across distinct major psychiatric disorders. A total of 1351 subjects affected by major depressive disorder (MDD = 389), bipolar disorder (BP = 511), delusional disorder (DD = 93) and schizophrenia (SKZ = 358) were included in our study. Subjects were assessed using the Operational Criteria for Psychotic Illness checklist (OPCRIT). The most frequently represented depressive symptoms in MDD were Loss of energy/tiredness, Loss of pleasure, Poor concentration, and Sleep disorders. Compared with MDD, BP had higher occurrences of Agitated activity, Excessive sleep, and Increased appetite and/or Weight gain, as well as lower Loss of pleasure. In our sample, 32.3% and 26.8% of DD and SKZ, respectively, had quite consistent depressive symptomatology, with at least four or more depressive symptoms. The most common depressive symptoms were Sleep disorders, Poor concentration and Loss of energy/Tiredness, followed by Psychomotor symptoms in SKZ only. Excessive self-reproach, Suicidal ideation, and Appetite and/or Weight changes were more specific to mood disorders. Finally, compared with SKZ, DD suffered from more depressive symptoms and had more severe depressive symptomatology. A quite consistent level of depressive symptomatology is therefore present in subpopulations of delusional and schizophrenic subjects other than in affective subjects. We identified some symptoms that are common across all major psychoses and symptoms that are more specific to each group. Copyright 2004 Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15261708     DOI: 10.1016/j.psychres.2003.12.025

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

Review 1.  New directions for the treatment of depression: Targeting the photic regulation of arousal and mood (PRAM) pathway.

Authors:  Hannah E Bowrey; Morgan H James; Gary Aston-Jones
Journal:  Depress Anxiety       Date:  2017-05-10       Impact factor: 6.505

2.  Proteomic Analysis of the Antidepressant Effects of Shen-Zhi-Ling in Depressed Patients: Identification of Proteins Associated with Platelet Activation and Lipid Metabolism.

Authors:  Chao Chen; Yuan Hu; Xian-Zhe Dong; Xiao-Jiang Zhou; Li-Hua Mu; Ping Liu
Journal:  Cell Mol Neurobiol       Date:  2018-03-21       Impact factor: 5.046

Review 3.  Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.

Authors:  Stefan Cohrs
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 4.  Psychiatric comorbidities and schizophrenia.

Authors:  Peter F Buckley; Brian J Miller; Douglas S Lehrer; David J Castle
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

5.  Depression in schizophrenia: methodological artifact or distinct feature of the illness?

Authors:  Eran Chemerinski; Christopher Bowie; Hannah Anderson; Philip D Harvey
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2008       Impact factor: 2.198

6.  Metabonomic study on the antidepressant-like effects of banxia houpu decoction and its action mechanism.

Authors:  Zhanqiang Ma; Weiwei Ji; Rong Qu; Mingyan Wang; Wen Yang; Zhen Zhan; Qiang Fu; Shiping Ma
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-23       Impact factor: 2.629

7.  Metabolomic identification of biochemical changes induced by fluoxetine and imipramine in a chronic mild stress mouse model of depression.

Authors:  Jing Zhao; Yang-Hee Jung; Choon-Gon Jang; Kwang-Hoon Chun; Sung Won Kwon; Jeongmi Lee
Journal:  Sci Rep       Date:  2015-03-09       Impact factor: 4.379

8.  Identifying the active components of Baihe-Zhimu decoction that ameliorate depressive disease by an effective integrated strategy: a systemic pharmacokinetics study combined with classical depression model tests.

Authors:  Ming Zhong; Xiaoting Tian; Shuoji Chen; Mingcang Chen; Ziqiong Guo; Minna Zhang; Gongpu Zheng; Zhixiong Li; Zhangpeng Shi; Guanghui Wang; Honggang Gao; Fang Liu; Chenggang Huang
Journal:  Chin Med       Date:  2019-09-24       Impact factor: 5.455

9.  Alterations in Metabolome and Microbiome Associated with an Early Stress Stage in Male Wistar Rats: A Multi-Omics Approach.

Authors:  Julia Hernandez-Baixauli; Pere Puigbò; Nerea Abasolo; Hector Palacios-Jordan; Elisabet Foguet-Romero; David Suñol; Mar Galofré; Antoni Caimari; Laura Baselga-Escudero; Josep M Del Bas; Miquel Mulero
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

10.  Pairwise common variant meta-analyses of schizophrenia with other psychiatric disorders reveals shared and distinct gene and gene-set associations.

Authors:  William R Reay; Murray J Cairns
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.